实施药物和酒精环境下共病精神障碍管理的多模式培训计划:共病护理途径(PCC)。

IF 1.5 4区 医学 Q3 PSYCHIATRY Journal of Dual Diagnosis Pub Date : 2021-10-01 Epub Date: 2021-10-26 DOI:10.1080/15504263.2021.1984152
Eva Louie, Kirsten C Morley, Vicki Giannopoulos, Gabriela Uribe, Katie Wood, Christina Marel, Katherine L Mills, Maree Teesson, Michael Edwards, Steven Childs, David Rogers, Adrian Dunlop, Andrew Baillie, Paul S Haber
{"title":"实施药物和酒精环境下共病精神障碍管理的多模式培训计划:共病护理途径(PCC)。","authors":"Eva Louie,&nbsp;Kirsten C Morley,&nbsp;Vicki Giannopoulos,&nbsp;Gabriela Uribe,&nbsp;Katie Wood,&nbsp;Christina Marel,&nbsp;Katherine L Mills,&nbsp;Maree Teesson,&nbsp;Michael Edwards,&nbsp;Steven Childs,&nbsp;David Rogers,&nbsp;Adrian Dunlop,&nbsp;Andrew Baillie,&nbsp;Paul S Haber","doi":"10.1080/15504263.2021.1984152","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to evaluate the impact of the Pathways to Comorbidity Care (PCC) training program for alcohol and other drugs (AOD) clinicians to improve the management of comorbidity.</p><p><strong>Methods: </strong>A controlled before-and-after study using PCC training was conducted across 6 matched sites in Australia including 35 clinicians. Controls received standard workplace training. PCC training included seminar presentations, workshops conducted by local \"clinical champions,\" individual clinical supervision, and access to an online information portal. We examined (a) identification (screening, assessment) and treatment (treatment, referral) of comorbidity in practice (<i>N</i> = 10 clinical files per clinician), (b) self-efficacy, knowledge, and attitudes of clinicians.</p><p><strong>Results: </strong>Significant improvements were observed in the PCC group but not the control sites with regards to the rate of clinical files showing identification of comorbidity (+50% v -12% change from baseline, respectively; [<i>X<sup>2</sup></i> (1, <i>N</i> = 340) = 35.29, <i>p</i> = .01] with only a trend for improvements in the rate of files demonstrating treatment of comorbidity [<i>X<sup>2</sup></i> (1, <i>N</i> = 340) = 10.45, <i>p</i> = .06]. There were significant improvements in the PCC relative to the control group for clinician self-efficacy, <i>F</i>(1,33) = 6.40, <i>p</i> = .02 and knowledge and attitudes of comorbidity monitoring, <i>F</i>(1,33) = 8.745, <i>p</i> = .01.</p><p><strong>Conclusions: </strong>The PCC training package may help improve identification of comorbidity, self-efficacy, and attitudes toward screening and monitoring of comorbidity in drug and alcohol settings.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC).\",\"authors\":\"Eva Louie,&nbsp;Kirsten C Morley,&nbsp;Vicki Giannopoulos,&nbsp;Gabriela Uribe,&nbsp;Katie Wood,&nbsp;Christina Marel,&nbsp;Katherine L Mills,&nbsp;Maree Teesson,&nbsp;Michael Edwards,&nbsp;Steven Childs,&nbsp;David Rogers,&nbsp;Adrian Dunlop,&nbsp;Andrew Baillie,&nbsp;Paul S Haber\",\"doi\":\"10.1080/15504263.2021.1984152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>We aimed to evaluate the impact of the Pathways to Comorbidity Care (PCC) training program for alcohol and other drugs (AOD) clinicians to improve the management of comorbidity.</p><p><strong>Methods: </strong>A controlled before-and-after study using PCC training was conducted across 6 matched sites in Australia including 35 clinicians. Controls received standard workplace training. PCC training included seminar presentations, workshops conducted by local \\\"clinical champions,\\\" individual clinical supervision, and access to an online information portal. We examined (a) identification (screening, assessment) and treatment (treatment, referral) of comorbidity in practice (<i>N</i> = 10 clinical files per clinician), (b) self-efficacy, knowledge, and attitudes of clinicians.</p><p><strong>Results: </strong>Significant improvements were observed in the PCC group but not the control sites with regards to the rate of clinical files showing identification of comorbidity (+50% v -12% change from baseline, respectively; [<i>X<sup>2</sup></i> (1, <i>N</i> = 340) = 35.29, <i>p</i> = .01] with only a trend for improvements in the rate of files demonstrating treatment of comorbidity [<i>X<sup>2</sup></i> (1, <i>N</i> = 340) = 10.45, <i>p</i> = .06]. There were significant improvements in the PCC relative to the control group for clinician self-efficacy, <i>F</i>(1,33) = 6.40, <i>p</i> = .02 and knowledge and attitudes of comorbidity monitoring, <i>F</i>(1,33) = 8.745, <i>p</i> = .01.</p><p><strong>Conclusions: </strong>The PCC training package may help improve identification of comorbidity, self-efficacy, and attitudes toward screening and monitoring of comorbidity in drug and alcohol settings.</p>\",\"PeriodicalId\":46571,\"journal\":{\"name\":\"Journal of Dual Diagnosis\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Dual Diagnosis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15504263.2021.1984152\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/10/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Dual Diagnosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15504263.2021.1984152","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 6

摘要

目的:我们旨在评估共病护理途径(PCC)培训计划对酒精和其他药物(AOD)临床医生改善共病管理的影响。方法:在澳大利亚6个匹配的地点进行了一项使用PCC培训的前后对照研究,其中包括35名临床医生。控制组接受了标准的工作场所培训。PCC培训包括研讨会报告、由当地“临床冠军”举办的讲习班、个人临床监督以及访问在线信息门户。我们检查了(a)在实践中对合并症的识别(筛选、评估)和治疗(治疗、转诊)(N =每位临床医生10个临床档案),(b)临床医生的自我效能、知识和态度。结果:PCC组在显示共病的临床文件率方面观察到显著改善,但对照组没有(分别比基线变化+50% v -12%;[X2 (1, N = 340) = 35.29, p = 0.01],只有合并症的治疗率有改善的趋势[X2 (1, N = 340) = 10.45, p = 0.06]。与对照组相比,PCC组临床医生自我效能感(F(1,33) = 6.40, p = 0.02)和共病监测知识和态度(F(1,33) = 8.745, p = 0.01)均有显著改善。结论:PCC培训包可能有助于提高对药物和酒精环境中共病的识别、自我效能和对筛查和监测共病的态度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC).

Objectives: We aimed to evaluate the impact of the Pathways to Comorbidity Care (PCC) training program for alcohol and other drugs (AOD) clinicians to improve the management of comorbidity.

Methods: A controlled before-and-after study using PCC training was conducted across 6 matched sites in Australia including 35 clinicians. Controls received standard workplace training. PCC training included seminar presentations, workshops conducted by local "clinical champions," individual clinical supervision, and access to an online information portal. We examined (a) identification (screening, assessment) and treatment (treatment, referral) of comorbidity in practice (N = 10 clinical files per clinician), (b) self-efficacy, knowledge, and attitudes of clinicians.

Results: Significant improvements were observed in the PCC group but not the control sites with regards to the rate of clinical files showing identification of comorbidity (+50% v -12% change from baseline, respectively; [X2 (1, N = 340) = 35.29, p = .01] with only a trend for improvements in the rate of files demonstrating treatment of comorbidity [X2 (1, N = 340) = 10.45, p = .06]. There were significant improvements in the PCC relative to the control group for clinician self-efficacy, F(1,33) = 6.40, p = .02 and knowledge and attitudes of comorbidity monitoring, F(1,33) = 8.745, p = .01.

Conclusions: The PCC training package may help improve identification of comorbidity, self-efficacy, and attitudes toward screening and monitoring of comorbidity in drug and alcohol settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
13.60%
发文量
20
期刊介绍: Journal of Dual Diagnosis is a quarterly, international publication that focuses on the full spectrum of complexities regarding dual diagnosis. The co-occurrence of mental health and substance use disorders, or “dual diagnosis,” is one of the quintessential issues in behavioral health. Why do such high rates of co-occurrence exist? What does it tell us about risk profiles? How do these linked disorders affect people, their families, and the communities in which they live? What are the natural paths to recovery? What specific treatments are most helpful and how can new ones be developed? How can we enhance the implementation of evidence-based practices at clinical, administrative, and policy levels? How can we help clients to learn active recovery skills and adopt needed supports, clinicians to master new interventions, programs to implement effective services, and communities to foster healthy adjustment? The Journal addresses each of these perplexing challenges.
期刊最新文献
The Whys and Wherefores of Reducing Cannabis Use in Early Psychosis: A Qualitative Study of Service Users' Experiences of Quitting and the Support. Reduction of Psychosis Proneness in a Daycare Hospital Program for Patients with Severe Alcohol Use Disorder. Eligibility for Substance Use Clinical Trials Among Emergency Psychiatry Patients: The Impact of Exclusion Criteria. Examining Profiles and Treatment Outcomes in Dual Diagnosis: Comparison of Coordinated Treatment With Mental Health Services Versus Addiction Center Alone. A Real-World Data Analysis. Factors Associated With Increased Substance Use Disorder Care in VA PTSD Specialty Outpatient Treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1